Mahendra Gulabdas Patel 's Insider Trades & SAST Disclosures
Mahendra Gulabdas Patel 's most recent trade in Sera Investments & Finance India Ltd. was a Disposal of 1,856,175 Equity Shares done at an average price of Rs. 15.0 . Disclosure was reported to the exchange on June 14, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Mahendra Gulabdas Patel 's has made SAST transactions in Sera Investments & Finance India Ltd. recently where a Disposal of 1,856,175 shares done . Disclosure was reported to the exchange on June 14, 2024.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sera Investments | Mahendra Gulabdas Patel | Promoter | Disposal | 14 Jun 2024 | 1,856,175 | 0 (0%) | 3.71% | 15.0 | 27,824,063 | 13 Jun 2024 13 Jun 2024 |
Insider Trading | Equity Shares | Market Sale |
| Sera Investments | Mahendra Gulabdas Patel | Promoter | Disposal | 27 Jun 2024 | 1,856,175 | - | 2.86% | - | 13 Jun 2024 13 Jun 2024 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Mahendra Gulabdas Patel | Promoter & Director | Acquisition | 10 Dec 2022 | 12,800 | 675,000 (3.37%) | 0.06% | 359.0 | 4,595,712 | 09 Dec 2022 09 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendra Gulabdas Patel & PACs | Promoter | Acquisition | 13 Dec 2022 | 12,800 | 675,000 (3.37%) | 0.06% | - | 09 Dec 2022 09 Dec 2022 |
SAST (29(2)) | - | None | |
| Lincoln Pharma | Mahendra Gulabdas Patel & PACs (Revised) | Promoter | Acquisition | 04 May 2023 | 12,800 | 675,000 (3.37%) | 0.06% | - | 09 Dec 2022 09 Dec 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Mahendra Gulabdas Patel | Promoter & Director | Acquisition | 08 Dec 2022 | 23,500 | 662,200 (3.31%) | 0.12% | 358.4 | 8,421,930 | 08 Dec 2022 08 Dec 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendra Gulabdas Patel & PACs | Promoter | Acquisition | 09 Dec 2022 | 23,500 | 662,200 (3.31%) | 0.12% | - | 08 Dec 2022 08 Dec 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Mahendra Gulabdas Patel | Promoter & Director | Acquisition | 30 Nov 2022 | 30,500 | 638,700 (3.19%) | 0.15% | 324.2 | 9,888,100 | 30 Nov 2022 30 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendra Gulabdas Patel & PACs | Promoter | Acquisition | 06 Dec 2022 | 30,500 | 638,700 (3.19%) | 0.15% | - | 30 Nov 2022 30 Nov 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | MAHENDRABHAI GULABDAS PATEL | Promoter & Director | Acquisition | 18 Nov 2022 | 33,200 | 608,200 (3.04%) | 0.17% | 299.6 | 9,946,720 | 17 Nov 2022 17 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendra Gulabdas Patel & PACs | Promoter | Acquisition | 22 Nov 2022 | 33,200 | 608,200 (3.04%) | 0.17% | - | 17 Nov 2022 17 Nov 2022 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter & Director | Acquisition | 29 Sep 2021 | 24,000 | 575,000 (2.88%) | 0.12% | 381.6 | 9,158,880 | 27 Sep 2021 27 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter | Acquisition | 29 Sep 2021 | 24,000 | 575,000 (2.88%) | 0.12% | - | 27 Sep 2021 27 Sep 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Mahendrabhai Gulabdas Patel & PACs | Promoter | Acquisition | 22 Sep 2021 | 39,500 | 551,000 (2.76%) | 0.20% | - | 20 Sep 2021 21 Sep 2021 |
SAST (29(2)) | - | Market | |
| Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter & Director | Acquisition | 21 Sep 2021 | 35,000 | 551,000 (2.76%) | 0.18% | 383.5 | 13,422,500 | 21 Sep 2021 21 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter & Director | Acquisition | 21 Sep 2021 | 4,500 | 516,000 (2.58%) | 0.02% | 383.3 | 1,724,670 | 20 Sep 2021 20 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendra Gulabdas Patel | Promoter | Acquisition | 28 Aug 2020 | 10,000 | 511,500 (2.56%) | 0.05% | 243 | 2,430,000 | 28 Aug 2020 28 Aug 2020 |
Insider Trading | Equity Shares | Market Purchase |
| Lincoln Pharma | Mahendra Gulabdas Patel with PACs | Promoter | Acquisition | 29 Aug 2020 | 10,000 | 511,500 (2.56%) | 0.05% | - | 28 Aug 2020 28 Aug 2020 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.